Contact
 

State-of-the-Field

HOME MEMBER LIST WORKSHOPS TELECONFERENCES STATE-OF-THE-FIELD

The table provides an overview of the recently completed, ongoing, or planned projects to manufacture GMP-grade HIV Env proteins (or versions of such) for testing as part of HIV vaccine candidates in early-stage clinical trials. It is a “living document” and was last updated in November 2017.

application/pdf icon Download the document

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account